- March 15, 2022
- Newsletter
- 617-430-5616
Menu
Brand Name :
Inderal LA, Inderal XL, Inderal, Propranolol Hydrochloride ER, Hemangeol
Synonyms :
Inderal, Inderal XL
Class :
Non-cardio-selective beta blocker, Group II antiarrhythmics
Brand Name :
Inderal LA, Inderal XL, Inderal, Propranolol Hydrochloride ER, Hemangeol
Synonyms :
Inderal, Inderal XL
Class :
Non-cardio-selective beta blocker, Group II antiarrhythmics
Dosage Forms & Strengths
Oral solution:
20mg/5ml
40mg/5ml
Injectable solution:
1mg/ml
Tablet:
10,20,40,60,80mg
Immediate dose:
40
mg
Orally
every 12 hrs
Tablet
Do not exceed 640mg/day
Dose Adjustments
Maintenance dose:80-240mg orally, every 8-12 hours
Oral solution
4.28mg/ml
20mg/5ml
40mg/5ml
Tablet
10,20,40,60,80mg
Initial dose:
0.6
mg
Orally
every week
Tablet
Maintenance dose:1.7mg/kg for two weeks
may increase the AV blocking effect of alpha2 agonists
methyldopa/hydrochlorothiazide
may increase the AV blocking effect of alpha2 agonists
may increase the AV blocking effect of alpha2 agonists
may enhance the serum concentration of rizatriptan
may decrease the therapeutic effect of activated charcoal
may decrease the bronchodilatory effect of Beta2 agonists
may reduce the antihypertensive effect of beta-blockers
may reduce the antihypertensive effect of beta-blockers
may reduce the antihypertensive effect of beta-blockers
may reduce the antihypertensive effect of beta-blockers
may reduce the antihypertensive effect of beta-blockers
may increase the hypotensive effect of beta-blockers
may increase the hypotensive effect of beta-blockers
may increase the hypotensive effect of beta-blockers
may increase the hypotensive effect of beta-blockers
may increase the hypotensive effect of beta-blockers
may increase the hypotensive effect of beta-blockers
may increase the hypotensive effect of beta-blockers
may increase the hypotensive effect of beta-blockers
may increase the hypotensive effect of beta-blockers
may increase the hypotensive effect of beta-blockers
may increase the hypotensive effect of beta-blockers
may increase the hypotensive effect of beta-blockers
may increase the hypotensive effect of beta-blockers
may increase the hypoglycemic effect
may increase the hypoglycemic effect
may increase the hypoglycemic effect
may increase the hypoglycemic effect
may increase the hypoglycemic effect
may enhance the adverse/toxic effect of Cholinergic agonists
may enhance the adverse/toxic effect of Cholinergic agonists
may enhance the adverse/toxic effect of Cholinergic agonists
may enhance the adverse/toxic effect of Cholinergic agonists
may enhance the adverse/toxic effect of Cholinergic agonists
may increase the effect of alpha1-blockers
bunazosin (Not available in the United States)
may increase the effect of alpha1-blockers
may increase the effect of alpha1-blockers
may increase the effect of alpha1-blockers
may increase the effect of alpha1-blockers
may increase the effect of alpha1-blockers
bunazosin (Not available in the United States)
may increase the effect of alpha1-blockers
may increase the effect of alpha1-blockers
may increase the effect of alpha1-blockers
may increase the effect of alpha1-blockers
may increase the effect of antidiabetic agents
may increase the effect of antidiabetic agents
may increase the effect of antidiabetic agents
may increase the effect of antidiabetic agents
may increase the effect of antidiabetic agents
may increase the effect of antidiabetic agents
may increase the effect of antidiabetic agents
may increase the effect of antidiabetic agents
may increase the effect of antidiabetic agents
may increase the effect of antidiabetic agents
may increase the adverse effect of cholinergic agonists
may increase the adverse effect of cholinergic agonists
may increase the adverse effect of cholinergic agonists